Curaleaf Holdings (CURLF) Total Debt (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Total Debt of $512.9 million for Q4 2025, up 9.08% year-on-year from $470.2 million in Q4 2024, and up 9.08% on a QoQ basis from $470.2 million in Q4 2024.

Curaleaf Holdings (CURLF) Total Debt (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Total Debt for 7 consecutive years, with $512.9 million the latest figure, recorded in Q4 2025.

  • Quarterly Total Debt rose 9.08% year-over-year to $512.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $512.9 million (up 9.08% YoY) and the FY2025 annual result came in at $512.9 million, up 9.08% from the prior year.
  • Total Debt grew to $512.9 million in Q4 2025 per CURLF's latest filing, from $470.2 million in the prior quarter.
  • Over the last five years, Total Debt for CURLF reached as high as $610.8 billion in Q1 2022 and fell as low as $339.5 million in Q1 2021.
  • A 5-year average of $41.2 billion and a median of $512.9 million in 2025 frame the typical range for Total Debt.
  • Annual changes were most pronounced in 2022 — Total Debt surged 179799.44% — and 2024, when it fell 20.09%.
  • Year by year, Total Debt stood at $467.1 million in 2021, then increased by 26.17% to $589.3 million in 2022, then fell by 4.94% to $560.2 million in 2023, then declined by 16.06% to $470.2 million in 2024, then increased by 9.08% to $512.9 million in 2025.
  • According to Business Quant data, Total Debt over the past three periods registered $512.9 million, $470.2 million, and $467.2 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 11.45 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.63 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 28.76 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 7.15 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.34 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.81 Bn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 512.92 Mn
Dec 31, 2024 470.21 Mn
Sep 30, 2024 467.19 Mn
Jun 30, 2024 469.98 Mn
Dec 31, 2023 560.19 Mn
Sep 30, 2023 584.62 Mn
Jun 30, 2023 574.07 Mn
Dec 31, 2022 589.33 Mn
Sep 30, 2022 620.66 Mn
Jun 30, 2022 605.91 Mn
Mar 31, 2022 610.78 Bn
Dec 31, 2021 467.07 Mn
Sep 30, 2021 349.41 Mn
Jun 30, 2021 345.61 Mn
Mar 31, 2021 339.51 Mn
Dec 31, 2020 291.50 Mn
Sep 30, 2020 283.40 Mn
Dec 31, 2019 104.95 Mn